What is new in this report?Substantial progress has been made since publishing previous practice guidelines on intrauterine adhesions (IUAs) [1].Large-scale series, although retrospective, have reported clinical outcomes.Randomized controlled trials (RCTs) have investigated both primary and secondary adhesion prevention including solid and semi-solid barriers, although individual surgical techniques have not been rigorously studied.Recent human studies documenting successful pregnancy outcomes for bone marrow-derived stem cell (BMDSC) treatments following intermittent hysteroscopy are reported.This may provide a new avenue for research, although high quality data demonstrating efficacy are required before being introduced as a treatment option for women with symptomatic IUAs (Asherman syndrome).In order to encourage their wide dissemination, these guidelines are freely accessible on the GYNS and JMIG websites.
No takes yet. Share an insight, caveat, or question.
A 2017 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: